Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer

被引:2
|
作者
Maisonneuve, Patrick [1 ]
Lowenfels, Albert B.
机构
[1] European Inst Oncol, Milan, Italy
[2] New York Med Coll, Valhalla, NY 10595 USA
来源
关键词
D O I
10.1001/jama.297.23.2581-a
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2581 / 2581
页数:1
相关论文
共 50 条
  • [1] Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer - Reply
    Oettle, Helmut
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (23): : 2582 - 2582
  • [2] Should gemcitabine be used as adjuvant chemotherapy in patients with resectable pancreatic cancer?
    O'Neil, Bert H.
    Goldberg, Richard M.
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2007, 4 (07): : 362 - 363
  • [3] Should gemcitabine be used as adjuvant chemotherapy in patients with resectable pancreatic cancer?
    Pascal Hammel
    [J]. Nature Clinical Practice Oncology, 2007, 4 : 460 - 461
  • [4] Should gemcitabine be used as adjuvant chemotherapy in patients with resectable pancreatic cancer?
    Hammel, Pascal
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (08): : 460 - 461
  • [5] Should gemcitabine be used as adjuvant chemotherapy in patients with resectable pancreatic cancer?
    Bert H O'Neil
    Richard M Goldberg
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 : 362 - 363
  • [6] Gemcitabine adjuvant chemotherapy shows promise for resectable pancreatic cancer
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 (4): : 182 - 182
  • [8] Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy
    Matsui, Hiroto
    Hazama, Shoichi
    Sakamoto, Kazuhiko
    Shindo, Yoshitaro
    Kanekiyo, Shinsuke
    Nakashima, Masao
    Matsukuma, Satoshi
    Tokuhisa, Yoshihiro
    Iida, Michihisa
    Suzuki, Nobuaki
    Yoshimura, Kiyoshi
    Takeda, Shigeru
    Ueno, Tomio
    Yoshino, Shigefumi
    Oka, Masaaki
    Nagano, Hiroaki
    [J]. PANCREAS, 2017, 46 (08) : 994 - 1002
  • [9] hENT1's role in adjuvant intra-arterial gemcitabine-based chemotherapy for resectable pancreatic cancer patients
    Wang, Wei
    Yu, Xinzhe
    Li, Hengchao
    Yang, Chuanxin
    Jin, Chen
    Huang, Xinyu
    [J]. BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [10] hENT1’s role in adjuvant intra-arterial gemcitabine-based chemotherapy for resectable pancreatic cancer patients
    Wei Wang
    Xinzhe Yu
    Hengchao Li
    Chuanxin Yang
    Chen Jin
    Xinyu Huang
    [J]. BMC Gastroenterology, 23